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Hypercalcemic Nephropathy 
in the Dog 
Ellen B. Hikes, DVM· 
Wallace B. Morrison, DVM·· 
INTRODUCTION 
Calcium is a functionally important ion and 
coenzyme in most all of the body systems. Be-
sides its structural role in bone, calcium is in-
volved in muscle contraction, the blood coag-
ulation system, enzyme activity, nerve 
impulse transmission, hormone release and 
membrane permeability.I-3 Calcium metabo-
lism is regulated primarily by parathyroid 
hormone (PTH), calcitonin (CT), and vi-
tamin D (1,25-dihydroxycholecalciferol).1.1.4 
The release of these hormones is controlled by 
the concentration of calcium in the plasma. 5 
Exact regulation of calcium in extracellular 
fluid is necessary to maintain normal body 
function. 
The skeleton contains approximately 99 
percent of the body's calcium stores. Only one 
percent of the total calcium is found outside 
the skeleton and one-tenth of one percent in 
the extracellular fluid. 4 •6 The extracellular 
pool of calcium is readily available for rapid 
exchange with intracellular stores.6 •7 Total 
serum calcium (extra-cellular calcium) is 
present in three forms; protein-bound (50 %), 
complexed (10%) and ionized calcium 
(40 % ).8 Ionized calcium is the biologically ac-
tive fraction.6.9 In most cases, total serum cal-
cium, not just ionized calcium, is measured 
due to the technical equipment required. 
Measurement of ionized calcium alone re-
quires that blood be collected anaerobically 
and analyzed soon after collection.3.l0 Ionized 
calcium values usually parallel changes in to-
tal calcium. It is necessary to interpret total 
serum calcium results in the context of the 
plasma albumin concentration and the acid-
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base status of the animal. 
The ratio of ionized calcium to protein-
bound calcium is altered by fluctuations in 
acid-base balance. Alkalosis decreases the per-
centage of ionized calcium by increasing the 
protein-bound fraction. Acidosis increases the 
percentage of ionized calcium.3.6·lI Approxi-
mately one-half of the calcium bound is to 
protein, primarily albumin. Interpretation of 
total calcium depends on concurrent values 
for serum albumin and total protein. 9 A posi-
tive linear relationship exists between total 
serum calcium and both serum total protein 
and albumin. J.ll In order to obtain more 
complete information about serum ionized 
calcium concentration, a correction formula 
for total serum calcium was derived on the 
basis of serum concentrations of albumin and 
total protein. The formula for calculating total 
serum calcium based on albumin concentra-
tions is: 
Adjusted calcium (mg/dl) = 
Calcium (mg!dl)-Albumin (g/dl)+3.5 
The correction formula based on total serum 
protein concentration is: 
Adjusted calcium (mg/dl) = Calcium (mg! 
dl)-OA [Total Serum Protein (g/dl)] +3.3 
The correction formulas account for the ef-
fects of the quantity of protein,3.9 but not for 
the effects of acid-base fluctuations on protein-
binding of calcium. Calcium-adjustment for-
mulas can determine whether hypocalcemia 
or a hypercalcemia are masked by abnormal 
serum protein concentration.' Hypoproteine-
mia can decrease the measured calcium, and 
hyperproteinemia will increase measured cal-
cium.6 As serum protein concentrations de-
crease, more calcium is ionized and then re-
moved from the serum by CT regulatory 
mechanisms. This results in an absolute de-
crease in serum calcium. Albumin is the most 
important calcium binder, binding approxi-
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mately 90 percent of the protein-bound cal-
cium. Therefore, it is more advantageous to 
use the correcting formula based on albumin 
rather than total protein. 3.6 
The normal total serum calcium value for 
the mature dog is approximately 10.0 mg/dl 
(9.4-12.2 mg/dl) with variations due to diet 
and analytical method.6.8·1o It is not unusual 
to see young, rapidly growing dogs with val-
ues approaching 12.0 mg/dl. General values 
for young dogs are approximately 11.1 ± 0.4 
mg/dl (to.5 to 11.5 mg/dl).13 Older dogs 
(greater than eight years of age) may have 
normal serum calcium values of 9.0 mg/dl.s 
There appears to be no breed- or sex-related 
differences in total serum calcium concentra-
tion. The total serum calcium concentration 
represents a balance between intestinal ab-
sorption, bone resorption and accretion, and 
renal excretion and reabsorption. Hypercalce-
mia exists when serum calcium levels rise 
above the normal value of 12 mg/d1.4.5.10.11 
Persistent hypercalcemia is indicated by in-
creased serum calcium concentration on two 
or more consecutive determinations and may 
indicate the presence of parathyroid, renal or 
neoplastic disease.1.13•14 Table 1 lists the dif-
ferential diagnoses of symptomatic hyper-
calcemia in order of most likely occur-
rence. 10.11•13 
TABLE 1. 
Differential Diagnosis 
1. Malignancy: Cancer-associated hypercalcemia 
Lymphosarcoma 
Adenocarcinoma (apocrine glands of the anal 
sac) 
Other (Multiple myeloma, mammary tumors) 
2. Hypoadrenocorticism 
3. Renal failure 
4. Bone lesion 
Metastatic 
Septic - bacterial or mycotic osteomyelitis 
Disuse osteoporosis 
5. Hypervitaminosis D 
Iatrogenic - diet 
Plants - Cestrum diumum 
Solanum malacoxylon 
Trisetum jlavescens 
6. Primary hyperparathyroidism 
Adenoma 
Adenocarcinoma 
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PATHOGENESIS OF HYPERCALCEMIA 
Neoplasia is the most common cause of hy-
percalcemia in the dog, with lymphosarcoma 
the most commonly involved tumor. 5•10 Can-
cer-associated hypercalcemia, formerly re-
ferred to as pseudohyperparathyroidism, may 
be due to tumor metastases to the bone, con-
current parathyroid hyperplasia, or production 
of bone-resorbing factors by neoplastic cells. 13 
Hypercalcemia associated with tumors is usu-
ally caused by a malignant tumor of non-
parathyroid origin secreting a factor or factors 
which mimic the action of PTH.5 •6 •11.15 There 
is no evidence radiographically or at necropsy 
of bone metastasis in this syndrome. Labora-
tory findings in cases of lymphosarcoma may 
show hypercalcemia, normo- or hypophospha-
temia, azotemia, hypercalcinuria, hyperphos-
phaturia, and hyposthenuria. 11 The changes in 
calcium and phosphorus result from the action 
of PTH-like substances, but these substances 
are not inhibited by increases in serum cal-
cium.1u5 It should be noted that it is impor-
tant to measure and interpret serum calcium 
and phosphorus together, because their regula-
tion and control are interrelated.6 Studies have 
identified several hypercalcemic factors pro-
duced by tumors: parathyroid hormone-like 
peptides,15 prostaglandin El,16 osteoclast-ac-
tivating factor15 and non-vitamin D sterols.4 
The chemical substances produced by tumors 
and the mechanisms by which hypercalcemia is 
induced are apparently different for different 
types of tumors.11 Adenocarcinomas derived 
from apocrine glands of the anal sac are also an 
important cause of hypercalcemia in older fe-
male dOgs.6.10.17 Other neoplasms which may 
be involved in this syndrome include testicular 
interstitial cell tumors and carcinoma of the 
mammary gland, stomach, thyroid and 
lung.5.10.11.15 
Hypoadrenocorticism (canine Addison's dis-
ease) results in hyperkalemia, hyponatremia 
and hypochloridemia due to decreased produc-
tion of glucocorticoids and mineralocorticoids. 
In approximately 25 percent of the affected 
dogs, hypercalcemia will also be seen.13 The 
severity of hypercalcemia is correlated with the 
severity of hypoadrenocorticism. However, the 
hypercalcemia is usually mild, generally less 
than 13.5 mg/dl. 13•111 The exact cause of the 
rise in calcium levels is unknown. Several 
mechanisms have been proposed, and the most 
likely explanation involves diminished renal 
excretion of calcium due to increased tubular 
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reabsorption of calcium. IS Hypercalcemia as-
sociated with hypoadrenocorticism usually of-
fers a good prognosis because it is corrected 
following adequate corticosteroid therapy for 
the hypoadrenocorticism. 
Primary and secondary bone tumors and 
septic osteomyelitis are uncommon causes of 
hypercalcemia in the dog, but are seen more 
often in man as a mechanism of hypercalce-
mia. 19 Primary or secondary bone tumors may 
cause hypercalcemia via osteolysis of the bone. 
It has been hypothesized that there is increased 
resorption of bone without adequate compen-
satory urinary excretion of calcium.13 Asso-
ciated with changes in calcium are normal or 
moderately elevated serum phosphorus and al-
kaline phosphatase. 4 •1o These changes are the 
result of either mechanical destruction by the 
infiltrating tumor or by bone-resorbing factors 
such as prostaglandins or osteoclast-activating 
factor. 4 Primary tumors which may produce 
hypercalcemia include osteosarcoma and 
multiple myeloma. 4 Mammary gland, liver, 
lung and prostate carcinomas have the highest 
incidence of secondary bone tumors in the 
dog. ll Bacterial and mycotic osteomyelitis (his-
toplasmosis, coccidioidomycosis and blastomy-
cosis) may also produce a hypercalcemic 
state. 13 Bone changes are due to either sepsis 
and inflammation resulting in bone destruc-
tion; or production of bone-resorbing factors. 10 
Primary hyperparathyroidism is uncommon 
in animals. Most likely findings include a 
single functional adenoma of the parathyroid 
gland, which results in production of an excess 
amount of PTH. Blood chemistry findings in-
clude marked elevation of serum calcium, a 
decrease in phosphorus and an increase in 
serum alkaline phosphatase activity.6 There are 
usually radiographic changes indicating de-
mineralization, subperiosteal areas of cortical 
bone resorption, loss of lamina dura dentes, 
soft tissue mineralization and bone cystS. 4 •6 •10 
Primary Renal Disease 
Primary renal disease, chronic or acute, can 
cause' a hypercalcemic condition. However, it 
is often difficult to establish if the hypercalce-
mia is the cause of renal disease or the result of 
renal dysfunction. 6 Hypercalcemia is not a 
classic finding in chronic renal failure. Serum 
biochemistries show a normal to low calcium, 
increased phosphorus and increased serum 
concentrations of PTH.20 These dogs are usu-
ally azotemic. 13 In five to ten percent of the 
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dogs with chronic renal failure, calcium levels 
are 12.0 mg/dl or greater. IO The pathogenesis 
of hypercalcemia induced by primary renal dis-
ease is not fully understood, and several mech-
anisms have been proposed: a) decreased ex-
cretion of calcium by the diseased kidney; b) 
decreased renal tubular degradation of PTH; 
c) PTH-induced hypercitricemia which in-
creases complexed calcium; d) overcompensa-
tion by the parathyroid gland; and e) exagger-
ated response to vitamin D with resultant 
increase in intestinal absorption of calcium. 10 
It now appears that the parathyroid glands-and 
increased concentration of PTH are important 
in pathogenesis of hypercalcemia associated 
with chronic renal failure. 13 
Acute renal failure and hypercalcemia in 
man may often be preceded by rhabdomyoly-
sis. 4 •20 Rhabdomyolysis and associated hyper-
calcemia is rarely observed in dogs. In man, 
rhabdomyolysis will cause an acute tubular ne-
crosis.10 The causes of rhabdomyolysis in man 
include traumatic, drug-induced, association 
with malignant hyperthermia or idiopathic. 21 
In a case reported in a dog, traumatic damage 
to muscle resulted in dystrophic calcification of 
the muscle. 4 Damaged muscle is the site for 
calcium deposition during the oliguric phase of 
acute renal failure. 20 During the diuretic 
phase, the sequestered calcium is released from 
the tissues leading to hypercalcemia and hy-
perphosphatemia.lo.2o The release of a large 
amount of calcium may overwhelm the capac-
ity of the kidneys to excrete calcium. 
Clinical Signs 
Hypercalcemia causes a variety of clinical 
signs because it affects four major body sys-
tems: renal, gastrointestial, nervous and mus-
cular. The structural and functional effects of 
hypercalcemia depend upon the underlying 
cause and the duration and severity of the hy-
percalcemia. 
Gastrointestinal dysfunction is the result of 
decreased contractility of the smooth muscle. 
This may cause anorexia, vomiting and consti-
pation.4 •6 •15 Constipation may also result from 
reduced food and water intake and dehydra-
tion. Polydipsia and polyuria are also potential 
signs of hypercalcemia due to ADH inhibition 
at the collecting tubules of the renal medulla. 
The nervous system is affected because hy-
percalcemia depresses the excitability of nerv-
ous tissue and suppresses lower motor neuron 
activity.10,15 Behavioral changes, depression, 
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muscle twitching, or seizures may be seen. 10.16 
Depression is the most common neurologic 
change seen in dogs. In severe cases, a dog 
may be in a stupor or coma. Mild or chronic 
hypercalcemia may produce no neurologic ab-
normalities. 6 
Both skeletal and cardiac muscles can be af-
fected. There is a general muscular weakness 
due to a decrease in muscle tone and there may 
be specific cardiac changes due to the hyper-
calcemia. Mild hypercalcemia may cause only 
hypertension. 20.21 With moderate to severe hy-
percalcemia, there may be arrhythmias, short-
ening of the Q-T interval, and prolongation of 
the P-R interval seen on electrocardio-
grams. 19.21 In severe cases, premature ventric-
ular contractions or ventricular tachycardia 
may be seen.4 Cardiac and renal tissues may 
also undergo mineralization. Hypertension, 
documented in man but not yet in dogs, may 
be the result of hypercalcemic nephropathy, 
but is also seen when renal function is normal. 
Proposed mechanisms for hypertension in-
clude: a) direct or indirect effect of calcium on 
peripheral resistance; b) increased cardiac out-
put due to the positive inotropic effect of cal-
cium; or c) changes in the renin-angiotensin 
system. 21 
NORMAL KIDNEY FUNCTION AND 
CALCIUM 
The kidney is intimately involved in the reg-
ulation of serum calcium. Calcium absorption 
and excretion are under the influence of hor-
monal regulation. The amount of calcium in 
extracellular fluid, cells, and bone is primarily 
dependent on the amounts absorbed in the in-
testine and excreted by the kidney.19 Main-
tenance of serum calcium levels is controlled by 
PTH, vitamin D, and target organ activity. 
Parathyroid hormone is secreted in response to 
fluctuations in ionized calcium and acts on 
bone and the kidney. Parathyroid hormone is 
also important in the formation of 1,25-dihy-
droxycholecalciferol (1,25(OH)2D3) from 25-
hydroxycholecalciferol (25(OH)D3) by the re-
nal cortex. 19 1,25-dihydroxycholecalciferol is 
the active form of vitamin D at the intestine 
where it promotes absorption of calcium and 
phosphate. This compound also has a role in 
both bone resorption and bone deposition. 
Without vitamin D, there is a decrease in the 
effect of PTH on bone resorption. Renal ac-
tivation of vitamin D is increased by PTH or a 
decrease in plasma phosphate. It is suppressed 
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by hypercalcemia. Since a fall in plasma cal-
cium will cause an increase in PTH secretion 
and concomitant increase in active vitamin D, 
the kidney has an important role in the regula-
tion of serum calcium concentration. 19.22 
Short-term calcium concentration is con-
trolled primarily by the effect of PTH on bone 
resorption. Long-term control results from the 
effect of PTH on reabsorprtion of calcium from 
kidney tubules and absorption of calcium via 
the gastrointestinal mucosa. 23 In the kidney, 
most of the serum calcium in the glomerular 
filtrate is reabsorbed in the proximal tubules 
and ascending limb of the loop of Henle. 19.2J.24 
In the distal tubules and collecting tubules the 
reabsorption of calcium becomes selective. 
This is most likely the site for independent reg-
ulation of calcium. 23 Parathyroid hormones 
will stimulate tubular calcium reabsorption 
and decrease phosphate reabsorption by activa-
tion of adenyl cyclase, to increase production 
of cyclic AMP. Parathyroid hormone has also 
been shown to alter renal blood flow and glo-
merular filtration rate. 7 
HYPERCALCEMIC NEPHROPATHY 
Increases in calcium can cause both struc-
tural and functional changes in the kidney. 
One of the earliest clinical manifestations of 
hypercalcemia is hyposthenuric polyuria with a 
compensatory polydipsia. The urine is hypos-
thenuric because calcium interferes with the 
normal response of the collecting tubules to 
antidiuretic hormone (ADH), thereby causing 
impairment of renal concentrating ability. One 
mechanism of calcium interference with ADH 
shows calcium damaging ADH receptors in the 
collecting tubules. This results in a decrease of 
ADH-binding. 1O Calcium also disrupts as-
sembly of cytoplasmic microtubules. It is pos-
tulated that these tubules are necessary to 
bring forth the hydrosmotic effects of ADH. 
With a decrease in these microtubules, water 
movement from the collecting duct lumen to 
the interstitium is impeded. 25 The result is a 
hyposthenuric polyuria that is resistant to the 
effects of exogenous ADH I5 .9 indicating that 
the hyposthenuria is renal in origin. 15 
Calcium is antagonistic to the adenyl cy-
clase-cyclic AMP system .. Hypercalcemia de-
creases cyclic AMP formation (via adenyl cy-
clase) in the distal convoluted tubules and 
collecting ducts. 4 •26 A decrease in cyclic AMP 
decreases the response to ADH. Calcium also 
inhibits the Na-K ATPase required for active 
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transport of sodium or chloride into the renal 
medullary interstitum. 10 This can result in in-
hibition of active transport of sodium chloride 
into the interstitium from the thick ascending 
limb of the loop of Henle and the distal tubules 
and collecting ducts. 25 With diminished so-
dium chloride reabsorption, there is a decrease 
in water reabsorption. Increased urine flow 
and sodium chloride loss, lead to hypovole-
mia.25 The decreased response to ADH pre-
vents urea accumulation in the inner medulla, 
which contributes to the concentrating defect. 19 
During this phase of polyuria and polydipsia, 
there is no elevation of blood urea nitrogen 
(BUN) or creatinine. If azotemia is present it 
may be due to; prerenal factors such as dehy-
dration from anorexia, vomiting, or water 
diuresis; or, renal factors such as a decrease in 
renal perfusion or intrarenal hydronephrosis. 10 
Renal failure initially can result from pre-
dominately prerenal factors, but if hypercalce-
mia persists, the renal failure may be due pri-
marily to acquired intrinsic renal tubular 
lesions.5 Effects of hypercalcemia on the kidney 
may range from mild and reversible damage to 
severe and progressive damage. Injury to renal 
tubular epithelium may be due to the direct 
toxic effect of increased calcium in serum and 
filtered tubular fluid. Calcium may also cause 
vasoconstriction of renal vessels (afferent arteri-
oles) resulting in ischemia and decreased renal 
blood flow. 10.15 
Initial injury results in focal degeneration in 
the ascending loop of Henle, distal convoluted 
tubule and collecting duct. Medullary struc-
tures (loops of Henle and collecting ducts) are 
involved first; probably because of higher me-
dullary calcium concentrations. 19 Earliest 
changes are at the intracellular level: mito-
chondrial distortion and injury in tubular epi-
thelial cells. Calcification begins with deposi-
tion of calcium-phosphorus complexes in the 
mitochondria. These complexes disrupt cell 
function and can lead to cell necrosis. lo Base-
ment membranes also become thickened and 
mineralized. A significant amount of tubular 
damage may occur without histologically de-
monstrable precipitates of calcium.ll In the 
early stages of hypercalcemia, glomeruli are 
not involved. If tubular basement membranes 
have not been damaged, the chances for rever-
sal of renal damage are good, assuming the 
cause of the hypercalcemia can be identified 
and eliminated.4 
Cast formation results from desquamated, 
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necrotic epithelial cells. These cells form casts 
which may become mineralized and obstruct 
the tubular lumen. Obstruction by calcium 
concretions predisposes to infection and focal 
pyelonephritis. lo•ll Calcified cellular debris 
may cause obstructive atrophy of nephrons. 27 
Damage to tubular basement membranes and 
cast formation markedly diminishes the ability 
of the kidney to regenerate.4 
As hypercalcemic damage progresses, there 
is increased mineralization of tubular epithe-
lium and basement membranes. Pathologic 
changes can be seen interstitially and within 
the tubules. These changes affect the distal tu-
bules and collecting ducts.21 The reversibility 
of renal damage depends on the extent of renal 
mineralization, the presence of intact tubular 
basement membranes and adequate numbers 
of remaining viable nephrons. 6 Advanced 
stages of severe or prolonged hypercalcemia 
are characterized by mineralization throughout 
the renal parenchyma, glomerular capillaries, 
Bowman's capsules and walls of vessels. 12.15 
Eventually, there is fibroblastic proliferation 
and inflltration with chronic inflammatory 
cells. 21 This leads to interstitial scarring and 
calcification, the hallmark of irreversible dam-
age. 19 
As mentioned previously, polyuria and poly-
dipsia are often the earliest recognized clinical 
signs. Hypercalcemia affects the glomerulus by 
causing a decrease in glomerular flltration rate. 
The decrease in G FR may be the result of cal-
cium-associated changes in glomerular capil-
lary permeability or volume contraction sec-
ondary to fluid losses. 6 A decrease in GFR may 
also be due to an increase in PTH.24 Hyper-
calcemia affects the loop of Henle by inhibiting 
calcium and magnesium reabsorption. In the 
distal tubules and collecting ducts there is selec-
tive impairment of calcium reabsorption24 in 
addition to the effects of calcium on ADH. As 
damage progresses, renal insufficiency be-
comes apparent. There is a continued decrease 
in GFR with a subsequent increase in BUN 
and creatinine levels. With progressive reduc-
tion in GFR, there is an increase in serum 
phosphorus and a decrease in urine calcium 
concentration. 
In determining renal involvement and estab-
lishing a diagnosis and a plan for treatment, it 
is necessary to evaluate several biochemical 
tests. Serum calcium should be repeated to rule 
out sample errors or changes due to the age of 
the dog and concentrations of albumin and 
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protein. 13 A complete blood count, complete 
serum chemistries, and electrolytes are helpful 
in ruling on several of the differential 
diagnoses. Chemistries should include serum 
phosphorus, BUN, creatinine and serum alka-
line phosphatase. A urinalysis can reveal gluco-
suria and proteinuria due to decreased tubular 
function, besides measuring specific gravity.' 
Other tests which are helpful in establishing a 
diagnosis include radiographic exam, electro-
cardiographic exam and possible biopsy. Table 
2 lists laboratory results and gross findings for 
the differential diagnosis of hypercalcemia. 
Once the serum calcium is restored to normal, 
treatment of the primary problem is indicated. 
Management of concomitant renal failure 
includes maintenance of adequate fluid and 
electrolyte balance, prevention of dehydration 
due to diuretic use, and correction of acid-base 
imbalances.4 •10 By maintaining adequate renal 
perfusion, the chances of ischemic damage to 
nephrons is decreased. No therapy will elimi-
nate renal lesions already present. If the hyper-
calcemia can be controlled and the dog kept 
alive long enough, tubular damage may be re-
paired by regeneration and functional adapta-
tion. 10 
TABLE 2. Differential Diagnosis of Hypercalcemia by Laboratory Tests and Gross Findings. tO 
Serum Serum Bone Soft Tissue Parathyroid 
Disease Calcium Phosphorus SAP Lesion Mineralization Lesion 
Primary 
hyper- Severe, Adenoma 
thyroidism High Low Elevated generalized Moderate Carcinoma 
Normal or Mild, Inactivity 
Malignancy High Low slightly elevated generalized Moderate or atrophy 
Osteolytic Normal or Moderately 
bone tumor High high elevated 
Vitamin D 
intoxication High High Normal 
TREATMENT 
Fluid volume expansion is the best sympto-
matic treatment for hypercalcemia. 13 Since 
many of the effects of hypercalcemia are accen-
tuated by dehydration, disturbances in fluid 
balance should be corrected in all cases. 4,10 
Fluid therapy with 0.9 percent sodium chloride 
intravenously will promote urinary excretion 
of calcium.:n In cases of mild hypercalcemia 
(less than 14 mg!dl), fluid replacement may be 
all that is necessary to decrease serum calcium. 
When calcium levels are greater than 14 mgt 
dl, diuretics such as furosemide or ethacrynic 
acid are effective as calciuretic agents. It is im-
portant to maintain adequate extracellular 
fluid volume while using these diuretics. 
Thiazide diuretics should not be used because 
they reduce urinary excretion of calcium.11 
Glucocorticoids may be effective in lowering 
serum calcium concentration by blocking cal-
cium absorption from the small intestine and 
increasing the renal excretion of calcium.4 In 
cases where the calcium levels exceed 16 mgt 
ell, sodium bicarbonate given intravenously 
may reduce the toxic effects of the calcium. 
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Focal, Inactivity 
muItifocai Moderate or atrophy 
Mild or 
absent Moderate Atrophy 
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